Matthias Alder - Net Worth and Insider Trading
Matthias Alder Net Worth
The estimated net worth of Matthias Alder is at least $73,050 dollars as of 2024-11-13. Matthias Alder is the EVP, Bus. Dev.&Lic, G.C. &Sec. of Sucampo Pharmaceuticals Inc and owns about 3,449 shares of Sucampo Pharmaceuticals Inc (SCMP) stock worth over $62,082. Matthias Alder is also the CEO of Gain Therapeutics Inc and owns about 5,286 shares of Gain Therapeutics Inc (GANX) stock worth over $10,968. Details can be seen in Matthias Alder's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthias Alder has not made any transactions after 2023-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthias Alder
Matthias Alder Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthias Alder owns 1 companies in total, including Gain Therapeutics Inc (GANX) .
Click here to see the complete history of Matthias Alder’s form 4 insider trades.
Insider Ownership Summary of Matthias Alder
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GANX | Gain Therapeutics Inc | 2023-12-21 | Chief Operating Officer |
Matthias Alder Latest Holdings Summary
Matthias Alder currently owns a total of 2 stocks. Among these stocks, Matthias Alder owns 3,449 shares of Sucampo Pharmaceuticals Inc (SCMP) as of November 28, 2016, with a value of $62,082 and a weighting of 84.99%. Matthias Alder also owns 5,286 shares of Gain Therapeutics Inc (GANX) as of December 21, 2023, with a value of $10,968 and a weighting of 15.01%.
Latest Holdings of Matthias Alder
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SCMP | Sucampo Pharmaceuticals Inc | 2016-11-28 | 3,449 | 18.00 | 62,082 |
| GANX | Gain Therapeutics Inc | 2023-12-21 | 5,286 | 2.08 | 10,968 |
Holding Weightings of Matthias Alder
Matthias Alder Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthias Alder has made a total of 0 transactions in Sucampo Pharmaceuticals Inc (SCMP) over the past 5 years. The most-recent trade in Sucampo Pharmaceuticals Inc is the sale of 150,000 shares on November 28, 2016, which brought Matthias Alder around $2 Million.
According to the SEC Form 4 filings, Matthias Alder has made a total of 2 transactions in Gain Therapeutics Inc (GANX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Gain Therapeutics Inc is the sale of 206 shares on December 21, 2023, which brought Matthias Alder around $507.
Insider Trading History of Matthias Alder
- 1
Matthias Alder Trading Performance
Matthias Alder Ownership Network
Ownership Network List of Matthias Alder
Ownership Network Relation of Matthias Alder
Matthias Alder Owned Company Details
What does Gain Therapeutics Inc do?
Who are the key executives at Gain Therapeutics Inc?
Matthias Alder is the Chief Operating Officer of Gain Therapeutics Inc. Other key executives at Gain Therapeutics Inc include Chief Financial Officer Charles Evan Ballantyne , Principal Accounting Officer Gianluca Fuggetta , and Chief Financial Officer Salvatore Calabrese .
Gain Therapeutics Inc (GANX) Insider Trades Summary
Over the past 18 months, Matthias Alder made 2 insider transaction in Gain Therapeutics Inc (GANX) with a net sale of 2,026. Other recent insider transactions involving Gain Therapeutics Inc (GANX) include a net purchase of 50,000 shares made by Khalid Islam , a net purchase of 30,000 shares made by Jeffrey Scott Riley , and a net purchase of 17,000 shares made by Eric I Richman .
In summary, during the past 3 months, insiders sold 0 shares of Gain Therapeutics Inc (GANX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,026 shares of Gain Therapeutics Inc (GANX) were sold and 111,400 shares were bought by its insiders, resulting in a net purchase of 109,374 shares.
Gain Therapeutics Inc (GANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gain Therapeutics Inc Insider Transactions
Matthias Alder Mailing Address
Above is the net worth, insider trading, and ownership report for Matthias Alder. You might contact Matthias Alder via mailing address: C/o Micromet, Inc., 6707 Democracy Blvd., Ste. 505, Bethesda Md 28017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
